Shinya Yamamoto on Clubhouse

Bio

Shinya Yamamoto, PhD experienced at domestic/ global CROs, major global trading company, technology-driven startup company and major global consulting firm, have engaged in clinical development, regulatory, consulting, corporate planning and business development. Founded Link & Innovation, Inc. in 2018, with various business schemes such as consulting, alliance, investment, co-founding, etc. with the global partners who are located in Silicon Valley, Beijing, Netherlands, Switzerland, UK, etc. Currently have been participating in the technology management of digital health startups and building an innovation portfolio in globally.
One of his innovation portfolio, Deep Intelligent Pharma Co., Ltd. was founded in Beijing, China as the world's first company of AI (artificial intelligence) engineers, in the sense that it was founded by an expert from global pharmaceutical company. Sequoia & SIG have been the Series B investor. The Tokyo office was established in April 2019, and actively promoting R&D process improvement proposals with a disruptive process innovation through digitalization for the biopharmaceutical industry and academia, currently.
His academic and the industry activities are as follows;
- Research Fellow, Research and Development Program "Science for Science and Technology
Innovation Policy", Research Institute of Science and Technology (RISTEX) (2012-2015)
- Co-Researcher, Clinical Research Center, Keio University School of Medicine (2013-2014)
- Part-Time Instructor, Hosei Business School of Innovation Management (2018-Present)
- Reference person, "Study Group for Reviewing the Japanese SBIR Program" led by the
“Cabinet Office”, “Ministry of Economy, Trade and Industry”, and “Small and Medium
Enterprise Agency” (2019)
- Program Committee Co-Chair, DIA Cutting Edge Series (2020-Present)